SCINNABIS
Science-based Medical Cannabis Products
Health Tech & Life Sciences
Non Active, Oct 2021 ceased to operate
Company Overview
Snapshot
Founded in July 2019 by Ben Peretz and Moran Mazuz, SCINNABIS operates with 1–10 employees. The company ceased operations in October 2021.
Business overview
SCINNABIS is a Health Tech & Life Sciences company focused on developing medical cannabis solutions. The company's core technology involves separating and re-integrating active ingredients in cannabis to create personalized medicine. SCINNABIS aims to develop science-based products with specific compositions to treat various medical indications, serving the Pharmaceuticals sector within the global market.
Log in to access full profile ›Company Intelligence Q&A
- When was SCINNABIS founded?
- SCINNABIS was founded in July 2019.
- Who are the founders of SCINNABIS?
- The co-founders of SCINNABIS are Ben Peretz and Moran Mazuz.
- What is SCINNABIS's primary focus?
- SCINNABIS focuses on developing science-based medical cannabis products by separating and re-integrating active ingredients to create personalized medicine for specific medical indications.
- What is the operational status of SCINNABIS?
- SCINNABIS ceased operations in October 2021 and is currently non-active.
- In which sector does SCINNABIS primarily operate?
- SCINNABIS primarily operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.